TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AVIR

Atea Pharmaceuticals Inc

Healthcare · Biotechnology

5.20$ +0.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Atea Pharmaceuticals Inc (AVIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 232 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AVIR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
608 595 553 510 491 465 440 392 343 315 267 232
603 590 549 506 487 462 434 386 336 311 263 229
138 144 161 243 98 65 119 88 77 96 79 77
595 578 541 502 483 455 425 380 329 302 256 219
26 40 49 34 32 26 29 27 27 40 33 28
19 32 41 27 25 19 22 20 20 40 33 28
0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.6 0.4
0.4 4.3 21 5.5 5.8 4.5 7.4 8.8 3.5 13 9.4 10
582 555 504 476 459 439 411 364 316 275 234 204
-157 -196 -259 -300 -331 -364 -398 -436 -478 -523 -568 -601
83 83 84 84 84 84 85 84 79 78 79 80

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?